Exploring the therapeutic potency of cryptotanshinone in cervical cancer: a multi-omics and network pharmacology

Zenghong Lu1, Gangfeng Zhu2, Xiaofei Feng1

  • 1Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.

Frontiers in Genetics
|December 12, 2024
PubMed
Abstract

Insights

Cryptotanshinone, derived from traditional Chinese medicine, shows promise in fighting cervical cancer by disrupting cancer cell growth and promoting cell death. This natural compound may offer a new therapeutic strategy for improving patient outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Bioinformatics

Background:

  • Cervical cancer presents a significant therapeutic challenge.
  • Novel strategies are needed to address its complex pathophysiology.
  • Cryptotanshinone is a derivative of Salvia miltiorrhiza, used in traditional Chinese medicine.

Purpose of the Study:

  • To elucidate the antineoplastic effects of cryptotanshinone on cervical cancer.
  • To investigate its potential therapeutic role using a multi-omics approach.

Main Methods:

  • Comprehensive multi-omics analysis (transcriptomic, proteomic).
  • Bioinformatics, data mining, and computational analysis.
  • Network pharmacology and pathway enrichment analyses.

Main Results:

  • Cryptotanshinone disrupts cancer cell proliferation and induces apoptosis.
  • Modulation of gene expression and protein networks identified.
  • Network pharmacology revealed a multi-targeted mechanism of action.
  • A prognostic model based on differentially expressed genes was established.

Conclusions:

  • Cryptotanshinone demonstrates potential as a therapeutic agent and prognostic biomarker for cervical cancer.
  • It offers a promising avenue for enhancing treatment efficacy and patient outcomes.
  • Further integration into therapeutic regimens is warranted.